Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: GENFIT

Market Cap 461M 535M 425M 398M 747M 50.89B 756M 5.03B 1.95B 24.74B 2.01B 1.96B 85.61B P/E Ratio 2025
-3.06x
P/E Ratio 2026 * 48.7x
Enterprise Value 406M 472M 374M 351M 659M 44.85B 667M 4.44B 1.72B 21.81B 1.77B 1.73B 75.45B EV / Sales 2025
2.34x
EV / Sales 2026 * 4.35x
Free-Float
86.88%
Yield 2025 *
-
Yield 2026 * -
1 day+3.25%
1 week+6.23%
Current month+5.86%
1 month+3.72%
3 months+9.71%
6 months+77.80%
Current year+80.59%
1 week 8.15
Extreme 8.15
9.39
1 month 8.15
Extreme 8.15
9.39
Current year 5.06
Extreme 5.055
9.67
1 year 3.43
Extreme 3.432
9.67
3 years 3.3
Extreme 3.305
9.67
5 years 2.96
Extreme 2.964
9.67
10 years 2.96
Extreme 2.964
21.74
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Change 5-day change 1-year change 3-year change Capi.($)
+3.25%+6.23% - - 534M
-0.35%+0.97%-13.80%-13.25% 43.03B
+3.11%+3.11%+279.08%+501.52% 32.71B
+0.22%-1.08%+15.66%-15.65% 30.29B
+1.62%-2.08%-1.91%+24.64% 29.4B
+4.09%+0.93%+12.97%+20.22% 25.08B
+1.14%+3.62% - - 13.54B
-1.63%+2.88%+56.69%+113.41% 13.35B
-0.40%-1.29%+6.23%+7.63% 12.97B
-0.74%-1.62%+105.89%+74.92% 12.11B
Average +1.03%+1.45%+57.60%+89.18% 23.61B
Weighted average by Cap. +1.06%+1.48%+57.30%+96.08%

Financials

2025 2026 *
Net sales 66.82M 77.58M 61.55M 57.68M 108M 7.37B 110M 729M 283M 3.59B 291M 285M 12.41B 95.2M 111M 87.69M 82.18M 154M 10.51B 156M 1.04B 404M 5.11B 414M 406M 17.68B
Net income -8.3M -9.64M -7.65M -7.17M -13.46M -916M -13.62M -90.62M -35.2M -446M -36.14M -35.37M -1.54B 18.31M 21.25M 16.86M 15.8M 29.67M 2.02B 30.03M 200M 77.61M 982M 79.69M 77.99M 3.4B
Net Debt -54.72M -63.53M -50.41M -47.24M -88.69M -6.04B -89.77M -597M -232M -2.94B -238M -233M -10.16B -46.87M -54.42M -43.17M -40.46M -75.96M -5.17B -76.89M -512M -199M -2.52B -204M -200M -8.7B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
188
Date Price Change
12/06/26 9.210 +3.25%
11/06/26 8.920 +6.19%
10/06/26 8.400 -0.83%
09/06/26 8.470 -2.98%
08/06/26 8.730 +0.69%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
9.260EUR
Average target price
14.00EUR
Spread / Average Target
+51.19%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!